|
|||||
|
|
| 国内糖尿病药物医院用药市场分析 | |
| 引用本文： | 汪启航,雷荣,廖凤霞.国内糖尿病药物医院用药市场分析[J].世界临床药物,2012,33(11):693-696. |
| 作者姓名： | 汪启航 雷荣 廖凤霞 |
| 作者单位： | 1. 重庆电子工程职业学院,重庆,401331 2. 重庆桐君阁股份有限公司,重庆,400012 3. 太极集团有限公司,重庆,401147 |
| 摘 要： | 本文采用药物综合数据库（PBD）提供的＂全国22大城市医院用药数据＂,结合国家食品药品监督管理局（SFDA）药品数据库和全国医药经济信息网信息资料,对糖尿病药物的主要品种市场份额、增长率和生产企业进行统计与分析,提出我国制药企业研发对策。 |
| 关 键 词： | 糖尿病药物 研发 对策 |
Analysis on diabetes drug's market in China |
|
| WANG Qi-hang , LEI Rong , LIAO Feng-xia.Analysis on diabetes drug's market in China[J].WORLD CLINICAL DRUGS,2012,33(11):693-696. | |
| Authors: | WANG Qi-hang LEI Rong LIAO Feng-xia |
| Institution: | 1.Chongqing College of Electronic Enginerring,Chongqing 401331;2.Chongqing Tongjunge limited Group,Chongqing 400012; 3.Chongqing Taiji Group,Chongqing 401147,China) |
| Abstract: | According to the 22 major city hospital medication data provided by pharma data base（PBD）,the drug product database from the National Pharmaceutical Economic Information Network and the information from State Food and Drug Administration（SFDA）,the main varieties of the diabetes drug market share,the growth rate and manufacturing enterprises are counts and analyzes in this review,and propose the research and development countermeasure for Chinese pharmaceutical companies. |
| Keywords: | diabetes drug research and development countermeasure |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |